Quick Answer
RedHill Biopharma Ltd. reported Total Assets of $18.04 million for the year ending 2024.
- RedHill Biopharma Ltd. showed a decrease of -21.7% in Total Assets from 2023 to 2024.
- This data is from RedHill Biopharma Ltd.'s annual report (Form 10-K), filed with the SEC on April 10, 2025.
- XBRL data for this metric is available from 2016 to 2024 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2016 to 2024), RedHill Biopharma Ltd.'s Total Assets has declined by 75.7%.
- Historical annual values: Fiscal year 2024: $18.04 million | Fiscal year 2023: $23.05 million | Fiscal year 2022: $158.87 million | Fiscal year 2021: $181.19 million | Fiscal year 2020: $180.24 million | Fiscal year 2019: $74.10 million | Fiscal year 2018: $62.41 million | Fiscal year 2017: $57.34 million | Fiscal year 2016: $74.21 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: